Trial Profile
Studies of Acute and Memory Immune Responses to Orally Administered Vaccines in Developing Country Children and Factors That May Augment Such Responses.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 15 Jul 2011
Price :
$35
*
At a glance
- Drugs Cholera vaccine inactivated (Primary) ; Typhoid-vaccine-Ty21a (Primary) ; Albendazole; Secnidazole
- Indications Cholera; Typhoid
- Focus Pharmacodynamics
- 11 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 25 Dec 2009 New trial record